Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients

Clin Nephrol. 2017 Apr;87 (2017)(4):188-195. doi: 10.5414/CN108986.

Abstract

Aims: To improve diagnosis and treatment, we characterized Fabry disease combined with IgA nephropathy and its response to treatment clinically and pathologically in Chinese patients.

Materials and methods: Clinical and pathological characteristics of 6 Chinese patients with renal biopsy-proven Fabry disease combined with IgA nephropathy were retrospectively analyzed.

Results: There were 4 males and 2 females in this study. All of the 6 patients presented with proteinuria. Microscopic hematuria was observed in case 4. Extrarenal symptoms included: acroparesthesia in case 1, 2, and 6, hypohidrosis in case 6 and angiokeratomas with hearing loss in case 3. By light microscopy, podocyte distension, with vacuolization, mesangial expansion, and interstitial lesions were found in all 6 cases; and focal segmental glomerulosclerosis was observed in 3 cases. Immunofluorescence microscopy showed deposition of IgA or predominant IgA with C3 in the mesangium. By electron microscopy, myelin figures and/or zebra bodies as well as electron-dense materials, were observed in the mesangium in the 6 cases. After admission and treatment with angiotensin converting enzyme inhibitors (ACEI) or angiotensin receptor blocker (ARB) together with immunosuppressant, glomerular filtration rate (GFR) decreased in 3 cases while it increased in the other 3 without statistical differences.

Conclusions: The clinical and pathological features of Fabry disease combined with IgA nephropathy are diverse. Therefore, it is important to combine family history, clinical manifestations, α-galactosidase A activity and pathological features, especially ultrastructural changes, to improve the diagnosis and treatment of the disease. .

MeSH terms

  • Adult
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Asian People
  • Fabry Disease / complications
  • Fabry Disease / metabolism*
  • Female
  • Glomerular Filtration Rate
  • Glomerular Mesangium / pathology
  • Glomerular Mesangium / ultrastructure
  • Glomerulonephritis, IGA / complications
  • Glomerulonephritis, IGA / drug therapy*
  • Glomerulosclerosis, Focal Segmental / drug therapy
  • Hematuria / etiology
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Podocytes / pathology
  • Podocytes / ultrastructure
  • Proteinuria / etiology
  • Retrospective Studies
  • Young Adult
  • alpha-Galactosidase / metabolism*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Immunosuppressive Agents
  • alpha-Galactosidase